The Lancet Oncology · 2017 · 219 citations · 25 references
MedicineOncologyPharmacotherapyCancer PharmacologyChemotherapyOncology PharmacotherapyMalignant NeoplasmsMalignant TumorsSquamous Cell CarcinomaMetastatic Squamous Cell CarcinomaPlacebo-controlled Efficacy AssessmentPlatinum-based RegimensRecurrent Tumor TrialsTherapy Response Evaluation
25
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Naiyer A. Rizvi, Matthew D. Hellmann, Alexandra Snyder et al. · Science · 2015 · 7.9K citations
Medicine, Immunology, Oncology +17
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
Robert L. Ferris, George R. Blumenschein, Jérôme Fayette et al. · New England Journal of Medicine · 2016 · 5.1K citations · Full text
Medicine, Oncology, Metastasis +5
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder, Vladimir Makarov, Taha Merghoub et al. · New England Journal of Medicine · 2014 · 4.4K citations · Full text
Medicine, Immunology, Oncology +17
Comprehensive genomic characterization of head and neck squamous cell carcinomas